Literature DB >> 34350530

Mice and Rats Exhibit Striking Inter-species Differences in Gene Response to Acute Stroke.

Qiu Jing Wu1,2, Xiujun Sun1, Lucy Teves1, Diana Mayor1,2, Michael Tymianski3,4,5.   

Abstract

Neuroprotection in acute stroke has not been successfully translated from animals to humans. Animal research on promising agents continues largely in rats and mice which are commonly available to researchers. However, controversies continue on the most suitable species to model the human situation. Generally, putative agents seem less effective in mice as compared with rats. We hypothesized that this may be due to inter-species differences in stroke response and that this might be manifest at a genetic level. Here we used whole-genome microarrays to examine the differential gene regulation in the ischemic penumbra of mice and rats at 2 and 6 h after permanent middle cerebral artery occlusion (pMCAO; Raw microarray CEL data files are available in the GEO database with an accession number GSE163654). Differentially expressed genes (adj. p ≤ 0.05) were organized by hierarchical clustering, correlation plots, Venn diagrams and pathway analyses in each species and at each time-point. Emphasis was placed on genes already known to be associated with stroke, including validation by RT-PCR. Gene expression patterns in the ischemic penumbra differed strikingly between the species at both 2 h and 6 h. Nearly 90% of significantly regulated genes and most pathways modulated by ischemia differed between mice and rats. These differences were evident globally, among stroke-associated genes, immediate early genes, genes implicated in stress response, inflammation, neuroprotection, ion channels, and signal transduction. The findings of this study may have significant implications for the choice of species for screening putative stroke therapies.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Animal stroke models; Gene expression and regulation; Microarray analysis; Pathophysiology

Mesh:

Year:  2021        PMID: 34350530     DOI: 10.1007/s10571-021-01138-8

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   4.231


  43 in total

1.  Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions.

Authors:  Michelle Aarts; Yitao Liu; Lidong Liu; Shintaro Besshoh; Mark Arundine; James W Gurd; Yu-Tian Wang; Michael W Salter; Michael Tymianski
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

2.  Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain.

Authors:  Douglas J Cook; Lucy Teves; Michael Tymianski
Journal:  Nature       Date:  2012-02-29       Impact factor: 49.962

3.  A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage.

Authors:  Anders Bach; Bettina H Clausen; Magda Møller; Bente Vestergaard; Celestine N Chi; Adam Round; Pernille L Sørensen; Klaus B Nissen; Jette S Kastrup; Michael Gajhede; Per Jemth; Anders S Kristensen; Patrik Lundström; Kate L Lambertsen; Kristian Strømgaard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-17       Impact factor: 11.205

Review 4.  Endogenous brain protection: what the cerebral transcriptome teaches us.

Authors:  K E M Cox-Limpens; A W D Gavilanes; L J I Zimmermann; J S H Vles
Journal:  Brain Res       Date:  2014-04-05       Impact factor: 3.252

5.  Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor.

Authors:  Bernt T Bråtane; Hong Cui; Douglas J Cook; James Bouley; Michael Tymianski; Marc Fisher
Journal:  Stroke       Date:  2011-09-08       Impact factor: 7.914

Review 6.  Rodent models of focal stroke: size, mechanism, and purpose.

Authors:  S Thomas Carmichael
Journal:  NeuroRx       Date:  2005-07

7.  Monofilament intraluminal middle cerebral artery occlusion in the mouse.

Authors:  W M Clark; N S Lessov; M P Dixon; F Eckenstein
Journal:  Neurol Res       Date:  1997-12       Impact factor: 2.448

8.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

Authors:  J B Bederson; L H Pitts; M Tsuji; M C Nishimura; R L Davis; H Bartkowski
Journal:  Stroke       Date:  1986 May-Jun       Impact factor: 7.914

9.  Reduction of the neuroprotective transcription factor Npas4 results in increased neuronal necrosis, inflammation and brain lesion size following ischaemia.

Authors:  Fong Chan Choy; Thomas S Klarić; Wai Khay Leong; Simon A Koblar; Martin D Lewis
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

10.  Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage.

Authors:  Bharath Chelluboina; Aditi Warhekar; Matt Dillard; Jeffrey D Klopfenstein; David M Pinson; David Z Wang; Krishna Kumar Veeravalli
Journal:  Sci Rep       Date:  2015-05-08       Impact factor: 4.379

View more
  1 in total

1.  Quantitative behavioral evaluation of a non-human primate stroke model using a new monitoring system.

Authors:  Toshikazu Hirohata; Takaya Kitano; Chizu Saeki; Kousuke Baba; Fumiaki Yoshida; Takashi Kurihara; Katsuhiro Harada; Shigeyoshi Saito; Hideki Mochizuki; Megumi Shimodozono
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.